Paediatric Hepatocellular Adenomas: Lessons from a Systematic Review of Relevant Literature

Overview

Journal JHEP Rep

Specialty Gastroenterology

Date 2024 May 3

PMID 38699071

Authors

Isabelle Scheers

Roberto Tambucci

Catherine de Magnee

Aurore Pire

Xavier Stephenne

Raymond Reding

Jean-Charles Nault

Affiliations

Soon will be listed here.

Abstract

Hepatocellular adenomas (HCAs) are rare benign liver tumours. Predisposing factors and complication rates appear to differ among children and adults. In the present study, we aimed to systematically characterise paediatric HCAs and determine their course, complications, and management. Medical history, clinical symptoms, imaging, histopathology, and genetics of children with HCAs were collected through a systematic and comprehensive review of the published literature. A total of 316 children with HCAs were included in the present study. HCAs were diagnosed primarily in girls (59.3%) and at a mean age of 11.5 (range 0-17.7) years. The majority (83.6%) of HCAs occurred in children with predisposing diseases, of which glycogen storage disease was the most common, followed by portosystemic shunts and MODY3 (maturity-onset diabetes of the young type 3). Each of these diseases leads to a well-defined HCA molecular pattern. A significant number of HCAs either bled (24.7%) or transformed (14.8%) over time. HCA transformation was significantly more frequent in children with portosystemic shunts and in β-catenin-mutated HCAs, while haemorrhages were more frequent in children exposed to hormones and those with larger lesions. Management was primarily guided by any predisposing conditions and the number of lesions. Therefore, vascular shunts were closed when possible, while complicated lesions were resected. Liver transplantation has made it possible to treat adenomatosis, as well as any underlying diseases. Progress in understanding genetic and/or malformative contributions, which appear to be significant in paediatric HCAs, have provided insights into tumour pathogenesis and will further guide patient surveillance and management.

References

Gjorgjieva M, Calderaro J, Monteillet L, Silva M, Raffin M, Brevet M . Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia. J Hepatol. 2018; 69(5):1074-1087. DOI: 10.1016/j.jhep.2018.07.017. View

McCuskey R, Vonnahme F, Grun M . In vivo and electron microscopic observations of the hepatic microvasculature in the rat following portacaval anastomosis. Hepatology. 1983; 3(1):96-104. DOI: 10.1002/hep.1840030116. View

Laumonier H, Cailliez H, Balabaud C, Possenti L, Zucman-Rossi J, Bioulac-Sage P . Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings. AJR Am J Roentgenol. 2012; 199(2):341-8. DOI: 10.2214/AJR.11.7046. View

Sala M, Gonzales D, Leste-Lasserre T, Dugot-Senant N, Paradis V, Di Tommaso S . ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice. Hepatol Commun. 2020; 4(6):809-824. PMC: 7262286. DOI: 10.1002/hep4.1514. View

Nault J, Couchy G, Caruso S, Meunier L, Caruana L, Letouze E . Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomas. Hepatology. 2018; 68(3):964-976. DOI: 10.1002/hep.29884. View

Lee Y, Kim G, Pan C, Mansfield B, Chou J . Minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia. Mol Genet Metab Rep. 2016; 3:28-32. PMC: 4750588. DOI: 10.1016/j.ymgmr.2015.03.001. View

Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C . Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature. 2008; 457(7226):200-4. PMC: 2695248. DOI: 10.1038/nature07475. View

Fukusato T, Soejima Y, Kondo F, Inoue M, Watanabe M, Takahashi Y . Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of β-catenin. Hepatol Res. 2014; 45(10):E32-42. DOI: 10.1111/hepr.12453. View

Keup C, Ratnaraj F, Chopra P, Lawrence C, Lowe L . Magnetic resonance imaging of the pediatric liver: benign and malignant masses. Magn Reson Imaging Clin N Am. 2013; 21(4):645-67. DOI: 10.1016/j.mric.2013.06.003. View

10.

Pilati C, Letouze E, Nault J, Imbeaud S, Boulai A, Calderaro J . Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation. Cancer Cell. 2014; 25(4):428-41. DOI: 10.1016/j.ccr.2014.03.005. View

11.

Rebouissou S, Franconi A, Calderaro J, Letouze E, Imbeaud S, Pilati C . Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression. Hepatology. 2016; 64(6):2047-2061. DOI: 10.1002/hep.28638. View

12.

Nault J, Couchy G, Balabaud C, Morcrette G, Caruso S, Blanc J . Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation. Gastroenterology. 2016; 152(4):880-894.e6. DOI: 10.1053/j.gastro.2016.11.042. View

13.

Zucman-Rossi J . Human and mouse hepatocellular adenoma and carcinoma display similar tumorigenesis pathway alterations. J Hepatol. 2008; 48(5):884-6. DOI: 10.1016/j.jhep.2008.02.001. View

14.

Pelletier L, Rebouissou S, Paris A, Rathahao-Paris E, Perdu E, Bioulac-Sage P . Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis. Hepatology. 2009; 51(2):557-66. DOI: 10.1002/hep.23362. View

15.

Chaturantabut S, Shwartz A, Evason K, Cox A, LaBella K, Schepers A . Estrogen Activation of G-Protein-Coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-Kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes. Gastroenterology. 2019; 156(6):1788-1804.e13. PMC: 6532055. DOI: 10.1053/j.gastro.2019.01.010. View

16.

Lofgren E, Tapanainen J, Koivunen R, Pakarinen A, Isojarvi J . Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy. Epilepsia. 2006; 47(9):1441-6. DOI: 10.1111/j.1528-1167.2006.00506.x. View

17.

Calderaro J, Labrune P, Morcrette G, Rebouissou S, Franco D, Prevot S . Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. J Hepatol. 2012; 58(2):350-7. DOI: 10.1016/j.jhep.2012.09.030. View

18.

Hull N, Schooler G, Lee E . Hepatobiliary MR Imaging in Children:: Up-to-Date Imaging Techniques and Findings. Magn Reson Imaging Clin N Am. 2019; 27(2):263-278. DOI: 10.1016/j.mric.2019.01.005. View

19.

Nault J, Paradis V, Ronot M, Zucman-Rossi J . Benign liver tumours: understanding molecular physiology to adapt clinical management. Nat Rev Gastroenterol Hepatol. 2022; 19(11):703-716. DOI: 10.1038/s41575-022-00643-5. View

20.

Godellas C, Fabri P, Knierim T, Rosemurgy A, Gower Jr W . Hepatic function after porto-systemic shunt. J Surg Res. 1992; 52(2):157-60. DOI: 10.1016/0022-4804(92)90298-e. View